Roles and regulation of stat family transcription factors in human breast cancer - PubMed (original) (raw)
Review
Roles and regulation of stat family transcription factors in human breast cancer
Charles V Clevenger. Am J Pathol. 2004 Nov.
Abstract
Stats (for signal transducers and activators of transcription) are a family of transcription factors that regulate cell growth and differentiation. Their activity is latent until phosphorylation by receptor-associated kinases. A sizable body of data from cell lines, mouse models, and human tissues now implicates these transcription factors in the oncogenesis of breast cancer. Because Stat activity is modulated by several posttranslational modifications and protein-protein interactions, these transcription factors are capable of integrating inputs from multiple signaling networks. Given this, the future utilization of Stats as prognostic markers and therapeutic targets in human breast cancer appears likely.
Figures
Figure 1
Activation and regulation of Stat-mediated transcription. After ligand-induced receptor dimerization, activated Jak sequentially phosphorylates receptor and Stat. This induces the release and dimerization of phosphorylated Stat, enabling its translocation into the nucleus and subsequent DNA binding. As indicated in the figure, Stat activity is regulated at many levels; events that stimulate Stat activity are noted with lines terminating in arrowheads, whereas inhibitory events are marked with lines ending with bars. Abbreviations: ub, ubiquitin; pY, phosphotyrosine; PTP, phosphatase. For the sake of simplicity some Stat regulatory events (ie, serine phosphorylation, protein-protein interactions, and so forth) have been omitted.
Figure 2
Structural maps of the Stat, SOCS, SHP, and PIAS protein families. Phosphorylated tyrosine and serine residues implicated in protein function are, respectively, designated pY and pS. The phosphatase domain is noted in the C-terminus of SHP (PTP). The signature leucine-rich motif conserved in the PIAS family is designated in the N-terminus of PIAS3 (LXXLL).
Figure 3
Mechanism for PRL/CypB induction of Stat5-induced gene expression. After receptor-mediated endocytosis, the transport of PRL into the nucleus is facilitated by its interaction with CypB. On entry into the nucleus, this complex interacts with Stat5 inducing the release of a repressor of its DNA-binding activity, namely PIAS3. The PRL/CypB-mediated release of PIAS3 from Stat5 results in significantly enhanced gene expression. Abbreviations: Pol, RNA polymerase II transcriptional apparatus; Sec61, ER transporter apparatus.
Similar articles
- Prognostic significance of signal transducer and activator of transcription 1 activation in breast cancer.
Widschwendter A, Tonko-Geymayer S, Welte T, Daxenbichler G, Marth C, Doppler W. Widschwendter A, et al. Clin Cancer Res. 2002 Oct;8(10):3065-74. Clin Cancer Res. 2002. PMID: 12374673 - The role of STATs in transcriptional control and their impact on cellular function.
Bromberg J, Darnell JE Jr. Bromberg J, et al. Oncogene. 2000 May 15;19(21):2468-73. doi: 10.1038/sj.onc.1203476. Oncogene. 2000. PMID: 10851045 Review. - Activation of Stat5a and Stat5b by tyrosine phosphorylation is tightly linked to mammary gland differentiation.
Liu X, Robinson GW, Hennighausen L. Liu X, et al. Mol Endocrinol. 1996 Dec;10(12):1496-506. doi: 10.1210/mend.10.12.8961260. Mol Endocrinol. 1996. PMID: 8961260 - STAT proteins as novel targets for cancer drug discovery.
Turkson J. Turkson J. Expert Opin Ther Targets. 2004 Oct;8(5):409-22. doi: 10.1517/14728222.8.5.409. Expert Opin Ther Targets. 2004. PMID: 15469392 Review. - Functional roles of STAT family proteins: lessons from knockout mice.
Akira S. Akira S. Stem Cells. 1999;17(3):138-46. doi: 10.1002/stem.170138. Stem Cells. 1999. PMID: 10342556 Review.
Cited by
- Reduction of phosphorylated signal transducer and activator of transcription-5 expression in feline mammary carcinoma.
Owaki K, Murakami M, Kato K, Hirata A, Sakai H. Owaki K, et al. J Vet Med Sci. 2024 Jul 2;86(7):816-823. doi: 10.1292/jvms.23-0470. Epub 2024 May 21. J Vet Med Sci. 2024. PMID: 38777776 Free PMC article. - Autophagy Modulation and Its Implications on Glioblastoma Treatment.
Chen J, Rodriguez AS, Morales MA, Fang X. Chen J, et al. Curr Issues Mol Biol. 2023 Oct 29;45(11):8687-8703. doi: 10.3390/cimb45110546. Curr Issues Mol Biol. 2023. PMID: 37998723 Free PMC article. Review. - Interplay between signal transducers and activators of transcription (STAT) proteins and cancer: involvement, therapeutic and prognostic perspective.
Jill N, Bhootra S, Kannanthodi S, Shanmugam G, Rakshit S, Rajak R, Thakkar V, Sarkar K. Jill N, et al. Clin Exp Med. 2023 Dec;23(8):4323-4339. doi: 10.1007/s10238-023-01198-8. Epub 2023 Sep 29. Clin Exp Med. 2023. PMID: 37775649 Review. - STAT family of transcription factors in breast cancer: Pathogenesis and therapeutic opportunities and challenges.
Wong GL, Manore SG, Doheny DL, Lo HW. Wong GL, et al. Semin Cancer Biol. 2022 Nov;86(Pt 3):84-106. doi: 10.1016/j.semcancer.2022.08.003. Epub 2022 Aug 19. Semin Cancer Biol. 2022. PMID: 35995341 Free PMC article. Review. - Breast Cancer and Prolactin - New Mechanisms and Models.
Clevenger CV, Rui H. Clevenger CV, et al. Endocrinology. 2022 Oct 1;163(10):bqac122. doi: 10.1210/endocr/bqac122. Endocrinology. 2022. PMID: 35922139 Free PMC article. Review.
References
- Schindler C, Shuai K, Prezioso VR, Darnell JE. Interferon-dependent tyrosine phosphorylation of a latent cytoplasmic transcription factor. Science. 1992;257:809–813. - PubMed
- Darnell JE. The JAK-STAT pathway: summary of initial studies and recent advances. Rec Prog Horm Res. 1996;51:391–404. - PubMed
- Zhong Z, Wen Z, Darnell JE. Stat3: a Stat family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6. Science. 1994;264:95–98. - PubMed
- Sadowski HB, Shuai K, Darnell JE, Gilman MZ. A common nuclear signal transduction pathway activated by growth factor and cytokine receptors. Science. 1993;261:1739–1744. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- CA92265/CA/NCI NIH HHS/United States
- CA102682/CA/NCI NIH HHS/United States
- R01 CA069294/CA/NCI NIH HHS/United States
- R01 CA69294/CA/NCI NIH HHS/United States
- R01 CA092265/CA/NCI NIH HHS/United States
- R01 CA102682/CA/NCI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous